Genalice

What Genalice does

Genalice BV is a Dutch private life sciences company headquartered in Nijkerk, Netherlands (operating across a dual model combining proprietary next-generation sequencing (NGS) bioinformatics software with e-commerce distribution of recombinant proteins, antibodies, and ELISA products. Founded in 2011 and employing 11–50 staff, the company targets life sciences researchers, diagnostic laboratories, and enterprise genomics services providers across use cases spanning AgriGenomics, rare diseases, population genetics, human genetics, reference migration, and oncology.

The software franchise is anchored by GENALICE MAP, a high-performance NGS read alignment and data analysis engine positioned on speed and scale, complemented by a cloud-native AWS deployment (GENALICE MAP AWS) and a clinical decision support module (Genalice Check) for NGS interpretation. Alongside this software business, Genalice runs a self-serve e-commerce storefront distributing third-party brands including Gentaur antibodies, Immunology Consultant Laboratory (ICL) ELISA kits, isotype and loading controls, and protein standards, plus 3DMed viral detection and RNA extraction kits. The company also offers its own Genelisa branded ELISA line and customization services for recombinant proteins, antibodies, and ELISAs. Product pricing is unit-based, ranging from roughly €300–€600 for standard antibody and protein SKUs to over €6,000 for specialized recombinant proteins.

Commercially, revenue is generated through one-time product sales on the storefront and subscription or licensing arrangements for GENALICE MAP, supported by phone-based EU customer support and self-serve online ordering. Disclosed enterprise relationships include Macrogen, which selected GENALICE MAP for large-scale genome analysis and clinical sequencing service data processing, and a strategic co-development alliance with KeyGene focused on accelerating plant DNA analysis. Leadership comprises Richard Irwin (CEO), Hans Karten (CTO), and Niall Moen (CFO). The firm remains privately held with no disclosed external funding rounds, parent company, or institutional ownership in the available data.

Name

Genalice

Legal name

Genalice BV

Website

https://genalice.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Genalice BV is a Dutch life sciences company combining proprietary NGS bioinformatics software (GENALICE MAP) with an e-commerce platform distributing antibodies, recombinant proteins, and ELISA products to research labs, diagnostic facilities, and enterprise genomics services providers.

Ownership category

akta.pro rank

Product category

Life Sciences Reagents and Bioinformatics

NAICS

Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

akta.pro secondary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Recombinant proteins
• Antibody products
• ELISA kits
• NGS data analysis
• Genomics software

Headquarters

HQ city

Harderwijk

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales: Sale of recombinant proteins, antibodies, and ELISA products through e-commerce platform. One-time purchase model with unit pricing per product.
2. NGS Software Solutions: Licensing of GENALICE MAP software for NGS data analysis, available as cloud solution or standalone product

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Genalice BV distributes and sells recombinant proteins, antibodies, and ELISA kits through its e-commerce platform, offering multi-brand product lines from Gentaur, Immunology Consultant Laboratory (ICL), and 3DMed, alongside its own Genelisa branded products. The company also develops and licenses GENALICE MAP, a high-performance NGS read alignment and data analysis software available as a cloud (AWS) or standalone solution for processing large-scale genome data. Customization services for recombinant proteins, antibodies, and ELISAs are offered to tailor products to specific research and diagnostic applications.

Product overview

Genalice BV operates as a life science products distributor offering a multi-brand portfolio through its e-commerce platform. The company distributes products from brands including Gentaur, Immunology Consultant Laboratory (ICL), and 3DMed, while also offering its own Genelisa branded products. The core offerings encompass recombinant proteins, antibodies (monoclonal, polyclonal across multiple species), ELISA kits, and related immunoassay reagents. Genalice positions customization services as a key differentiator, offering to customize recombinants, antibodies, and ELISAs for customers. The company is headquartered in Nijkerk, Netherlands, and maintains customer support through phone and an online platform.

Differentiator

Problem solved

Functional benefit

Brands

• Gentaur Antibodies: Antibody products including Goat, Human, Monoclonal, Mouse, Polyclonal, and Rabbit antibodies
• ICL Antibodies
• ICL ELISA
• ICL Isotype Control
• ICL Loading Control
• ICL Protein Standard
• Genelisa
• 3DMed

Products and services

• Antibodies (Gentaur and ICL brands) Distributed portfolio of antibodies covering multiple species (Rabbit, Human, Mouse, Goat, etc.) and formats (monoclonal, polyclonal) targeting viral pathogens (Dengue, Ebola, Chikungunya, Japanese Encephalitis, Influenza, Zika, Nipah, Lassa, Vaccinia), bacterial antigens, and cellular markers for life sciences research.
• Recombinant Proteins Recombinant proteins including Dengue NS1 antigens (Types 1-4), Plasmodium falciparum proteins, and various viral antigens sold via unit pricing (e.g., Purified GFP €348, specialized proteins reaching €6,110+). Targeted at research and diagnostic applications requiring validated recombinant antigens.
• ELISA Kits and Reagents (ICL and Genelisa) ELISA kits, substrates, and reagents for immunoassay applications including detection of viral antibodies and antigens, distributed from ICL and sold under the Genelisa own brand.
• 3DMed Viral Detection and RNA Extraction Products Viral detection and RNA extraction products from 3DMed, including the 96A Automated Viral RNA Isolation Kit based on Dynal magnetic beads technology designed for use with KingFisher Flex and Auto-Pure96 purification systems. Targeted at viral disease detection and diagnostics development.
• Genelisa Branded Products Genalice's own branded ELISA and immunoassay product line offered alongside the distributed brands, providing an own-label alternative within the Genalice e-commerce catalog.
• GENALICE MAP — NGS Data Analysis Software High-performance NGS read alignment and data analysis software for processing large-scale genome data, available as a standalone product or as a cloud (AWS) deployment. Used by enterprise customers such as Macrogen for large-scale genome analysis and clinical sequencing service data processing.
• Genalice Check — Clinical Decision Support Clinical decision support tool for NGS data interpretation, extending Genalice's software offerings into clinical applications such as diagnostic variant interpretation.
• Custom Recombinant Protein, Antibody, and ELISA Services Custom recombinant protein, antibody, and ELISA product development and manufacturing services for research and diagnostic customers requiring non-standard or tailored reagents.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• GentaurcoreChannel Partner/ Reseller/ DistributorGentaur is a brand whose antibodies and related products are distributed through Genalice BV's e-commerce platform. Products include Rabbit Antibodies, Human Antibodies, Monoclonal Antibodies, Mouse Antibodies, Goat Antibodies, and Polyclonal Antibodies.
• Immunology Consultant Laboratory (ICL)coreChannel Partner/ Reseller/ DistributorImmunology Consultant Laboratory products including ICL Antibodies, ICL ELISA, ICL Isotype Control, ICL Loading Control, and ICL Protein Standard are distributed through Genalice BV.
• 3DMedminorChannel Partner/ Reseller/ Distributor3DMed provides viral detection products including automated RNA isolation kits that are distributed through Genalice BV.
• KeyGenecoreStrategic or Co-development PartnerStrategic collaboration with KeyGene for speeding up plant DNA analysis. Joint efforts in advancing DNA analysis technology for agricultural genomics applications.
• MacrogencoreTechnology or IntegrationMacrogen selected GENALICE MAP to process large-scale genome analysis and clinical sequencing service data. Key customer relationship demonstrating enterprise-scale deployment of Genalice's NGS solutions.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Seven Bridges Genomics: Seven Bridges offers cloud-based NGS data analysis and bioinformatics pipelines for population genomics and clinical research. Direct peer to Genalice's GENALICE MAP, competing for the same large-scale genome analysis service-provider customers (Macrogen is a comparable archetype).
• DNAnexus: DNAnexus provides a cloud platform for genomics and biomedical data analysis with enterprise customers in clinical sequencing and pharma. Closely comparable to Genalice's GENALICE MAP AWS offering in cloud NGS data analysis business model and buyer profile.
• SOPHiA Genetics: SOPHiA Genetics sells genomics data analysis and clinical decision support for NGS-based diagnostics. Direct peer to the GENALICE MAP + Genalice Check combination, both targeting molecular diagnostics labs seeking analytics plus interpretation.
• Boster Bio: Boster Bio manufactures and sells antibodies, ELISA kits, and recombinant proteins directly via e-commerce to research labs. Direct peer to Genalice's reagent distribution business and customization service with similar channels and buyer profile.

Emerging players

• Sentieon: Sentieon provides high-accuracy NGS analysis algorithms (alignment, variant calling) optimized for production pipelines. Competes with GENALICE MAP on read alignment accuracy/speed for clinical and large-cohort sequencing workflows.

Broad incumbents

• Illumina (DRAGEN): Illumina is the dominant NGS instruments and software vendor; its DRAGEN platform offers accelerated NGS analysis competing head-on with GENALICE MAP. As a broad incumbent it bundles hardware, reagents, and analytics, raising the strategic bar for pure-play NGS software firms.
• QIAGEN: QIAGEN delivers molecular diagnostics reagents, sample-prep kits, and bioinformatics (e.g., Ingenuity, QIAseq). Comparable across Genalice's reagent distribution and clinical decision-support dimensions; a broad incumbent overlapping both sides of Genalice's business.
• Thermo Fisher Scientific: Thermo Fisher provides life science reagents, antibodies, ELISA kits and genomics analytics (e.g., Ion Torrent, bioinformatics). Broad incumbent comparator across Genalice's recombinant protein/antibody/ELISA distribution and NGS software lines.
• Bio-Rad Laboratories: Bio-Rad manufactures life science research and clinical diagnostics products including antibodies, ELISA kits and protein standards. Overlaps with Genalice's reagent distribution catalog (antibodies, ELISA, protein standards) via a much larger incumbent portfolio.

Regional players

• 2BScientific: 2BScientific distributes life science reagents including antibodies, proteins, and ELISA products, primarily serving the European research market via online catalog. Comparable e-commerce distributor model and product breadth to Genalice's Gentaur/ICL channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/GenaliceDNA

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genalice